CATS - Catasys, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
14.75
-0.34 (-2.25%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close15.09
Open15.00
Bid0.00 x 800
Ask0.00 x 800
Day's Range14.58 - 15.27
52 Week Range8.71 - 20.83
Volume113,138
Avg. Volume109,198
Market Cap246.449M
Beta (3Y Monthly)1.62
PE Ratio (TTM)N/A
EPS (TTM)-0.88
Earnings DateNov 13, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est23.75
  • Business Wire

    Catasys Announces 2019 Third Quarter Financial Results

    SANTA MONICA, Calif.-- -- Q3 2019 Record Revenue of $8.8 Million, Up 102% Year over Year and 15% from Q2 2019 Total Outreach Pool of Eligible Members of 140,000 in Q3 2019, Up 26% from 112,000 at Q2 2019 Net New Enrolled Members of 1,473 in Q3 2019, up 366% from 316 in the Same Period of Prior Year Secured $45 Million in Debt Financing from Goldman Sachs to Support Company’s Accelerating Growth Company ...

  • Hedge Funds Have Never Been More Bullish On Catasys, Inc. (CATS)
    Insider Monkey

    Hedge Funds Have Never Been More Bullish On Catasys, Inc. (CATS)

    Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]

  • Business Wire

    Catasys Schedules 2019 Third Quarter Financial Results Conference Call for November 13, 2019

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced that the Company will be releasing financial results for its third quarter ended September 30, 2019, after the closing of the stock market on Wednesday, November 13, 2019.

  • How Does Investing In Catasys, Inc. (NASDAQ:CATS) Impact The Volatility Of Your Portfolio?
    Simply Wall St.

    How Does Investing In Catasys, Inc. (NASDAQ:CATS) Impact The Volatility Of Your Portfolio?

    If you own shares in Catasys, Inc. (NASDAQ:CATS) then it's worth thinking about how it contributes to the volatility...

  • Business Wire

    Catasys to Present at Credit Suisse 28th Annual Healthcare Conference

    Catasys, Inc. (CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that Mr. Terren Peizer, the Company’s Chairman and CEO, is scheduled to present at the 28th Annual Healthcare Conference on Tuesday, November 12, 2019, at 4:10 p.m. MST. Catasys, Inc. is a leading AI and technology-enabled healthcare company whose mission is to help improve the health and save the lives of as many people as possible. By combining predictive analytics with human engagement, Catasys delivers improved member health and validated outcomes and savings to healthcare payers.

  • Benzinga

    14 Low Float Stocks With High Short Interest

    Low float stocks can be some of the most volatile stocks in the market. If you mix in a short squeeze, the potential short-term gains in a low float stock can be extreme. A stock’s float is the number ...

  • Thomson Reuters StreetEvents

    Edited Transcript of CATS earnings conference call or presentation 14-Aug-19 8:30pm GMT

    Q2 2019 Catasys Inc Earnings Call

  • Catasys (NASDAQ:CATS) Is Making Moderate Use Of Debt
    Simply Wall St.

    Catasys (NASDAQ:CATS) Is Making Moderate Use Of Debt

    Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

  • CATASYS INC (CATS) Q2 2019 Earnings Call Transcript
    Motley Fool

    CATASYS INC (CATS) Q2 2019 Earnings Call Transcript

    CATS earnings call for the period ending June 30, 2019.

  • Benzinga

    Q2 Earnings Preview For Catasys

    On Wednesday, August 14, Catasys (NASDAQ: CATS ) will report its last quarter's earnings. Here is Benzinga's preview of the company's release. Earnings and Revenue Sell-side analysts are expecting Catasys's ...

  • GlobeNewswire

    BriaCell Appoints Richard J. Berman to Board of Directors

    BERKELEY, Calif., and VANCOUVER, British Columbia, Aug. 12, 2019 -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage.

  • Analysts Estimate Catasys (CATS) to Report a Decline in Earnings: What to Look Out for
    Zacks

    Analysts Estimate Catasys (CATS) to Report a Decline in Earnings: What to Look Out for

    Catasys (CATS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • MoneyShow

    Catasys CATS- 2019 Top Picks' Mid-Year Update

    Nate Pile, editor of Nate's Notes, selected Catasys (CATS) as his top investment idea for 2019. The stock has since risen 105%. Here's his latest update on the health services provider.

  • Catasys (NASDAQ:CATS) Shareholders Have Enjoyed A Whopping 339% Share Price Gain
    Simply Wall St.

    Catasys (NASDAQ:CATS) Shareholders Have Enjoyed A Whopping 339% Share Price Gain

    Investing can be hard but the potential fo an individual stock to pay off big time inspires us. Not every pick can be...

  • Catasys Appoints Healthcare Executive Daniel Prewitt as Senior Vice President of Sales
    Business Wire

    Catasys Appoints Healthcare Executive Daniel Prewitt as Senior Vice President of Sales

    Catasys, Inc. , a leading AI and technology-enabled healthcare company, today announced the appointment of Daniel Prewitt as the senior vice president of sales.

  • GlobeNewswire

    Sharon R. Gabrielson Named Chair of Sharps Compliance Board of Directors

    Sharon Gabrielson joined the Sharps Compliance board in February 2019.  She is a progressive healthcare executive with over 30 years of broad-based leadership experience in the healthcare industry and currently serves as Chair of Global Business Solutions for the Mayo Clinic, where she is responsible for directing domestic and international business development opportunities for the Clinic’s healthcare products and services to the B2B and B2C markets.  Previously, Ms. Gabrielson was Vice Chair of Mayo’s Health System Administration, where she oversaw an organization of community-based practices including hospitals, clinics, nursing homes, and home health, which generated approximately $2 billion in revenues. Ms. Gabrielson has served on numerous leadership and management committees at Mayo Clinic, as well as industry boards including for-profit public and private, as well as not-for-profit and community organizations.